Tiotropium bromide is a long-acting anticholinergic agent that antagonizes muscarinic M3 receptors in the airways, leading to bronchodilation for COPD management. It is widely used in respiratory research, with applications in both in vitro receptor binding studies and in vivo models of obstructive lung disease to investigate bronchodilatory mechanisms.